@ARTICLE{Uslu_M._Determination_2022,
 author={Uslu, M. and Canbar, R. and Akcakavak, G. and Yazar, E.},
 volume={vol. 25},
 number={No 2},
 journal={Polish Journal of Veterinary Sciences},
 pages={357-359},
 howpublished={online},
 year={2022},
 publisher={Polish Academy of Sciences Committee of Veterinary Sciences},
 publisher={University of Warmia and Mazury in Olsztyn},
 abstract={The aim of this research was to determine the embryotoxic and teratogenic effects and lethal dose (LD50) of maropitant in ovo, using fertile chicken eggs. The study was designed in two stages, CHEST-I and CHEST-II. For CHEST-I, 210 fertile eggs were divided into seven equal groups; control, saline solution and 5 different doses of maropitant (10, 5, 2.5, 1.25, 0.625 mg/kg) injected groups. For CHEST-II, 150 fertile eggs were divided into five equal groups; control, saline solution and 3 different doses of maropitant (8, 6, 4 mg/kg)-injected groups. Eggs were opened on day 21 of incubation. Maropitant did not cause teratogenicity at any dose, while higher embryonic death rates were observed at doses above 4 mg/kg. The LD50 dose of maropitant was determined as 7.24 mg/kg. In conclusion, maropitant should only be used after full consideration of risks and benefits in pregnancy.},
 type={Short communication},
 title={Determination of the embryotoxic effect of maropitant using an in ovo model},
 URL={http://ochroma.man.poznan.pl/Content/123701/PDF-MASTER/19%20_%20Ulsu.pdf},
 doi={10.24425/pjvs.2022.141821},
 keywords={Maropitant, embryotoxicity, in ovo model},
}